Main Content

Elekta Neuromag® Functional Mapping

Functional Mapping with MEG

Functional mapping using magnetoencephalography (MEG) technology is a safe, noninvasive method for imaging human brain activity. MEG can measure this activity with millisecond precision, in addition to providing good spatial resolution. This makes MEG a powerful tool for studying the rapid brain events that underlie normal human cognitive processes as well as their disruption in disease states. There are about 160 MEG systems of all makes installed worldwide. 

Elekta Neuromag TRIUX*, Elekta’s latest generation MEG platform raises functional mapping to the next level, addressing key MEG requirements that are critical for robust functional mapping studies. The system features higher tolerance for magnetic interferences, new user interface features and patient comfort enhancements—making Elekta Neuromag TRIUX practical for virtually any clinical and research environment.

*Elekta Neuromag TRIUX is a works in progress. Specifications and product details subject to change without notice.


A guide for patients with epilepsy or brain tumor

Magnetoencephalography (mag NEE-TO en-SEFF uh-LAW graphy):

A completely noninvasive procedure that uses an array of highly sensitive sensors to detect and record the magnetic fields associated with electrical activity in the brain. This procedure usually is abbreviated as MEG. There are many clinical and research applications for which MEG may be useful, including determining the function of various parts of the brain and localizing epileptic activity.


 Elekta Neuromag® Magnetoencephalography (MEG) system for functional brain mapping

What is Neuromag?Clinicians and researchers are increasingly adopting the fast-growing technology of MEG for non-invasive investigations of the brain’s magnetic fields. The leading MEG provider, Elekta manufactures Elekta Neuromag, a sophisticated MEG system that is extensively used in pre-surgical localization of epilepsy and mapping of the eloquent cortex, including motor functions, hearing and vision.


 Elekta Neuromag® TRIUX

Elekta TRIUXAs the leader in MEG technology since the introduction of Elekta Neuromag in 1998, Elekta is pleased to introduce Elekta Neuromag TRIUX, a new magnetoencephalography (MEG) platform that raises functional mapping to the next level.


 Functional Mapping for clinical and research applications

Functional Mapping for clinical and research applicationsMEG has been proven to be of clinical utility, enabling improved patient management in the evaluation of epilepsy as well as the presurgical mapping of visual, auditory, somatosensory, motor cortex and language functional areas. Current estimates indicate that up to 25 percent or more of patients with epilepsy are refractory to all forms of medical therapy. These medically intractable patients are candidates for surgical treatment in an attempt to achieve better seizure control.